title: Elevated serum beta-2-microglobulin--a prognostic marker for development of AIDS among patients with persistent generalized lymphadenopathy.
abstract: For evaluation of its prognostic value, the level of serum beta-2-microglobulin was determined in early serum samples from 88 patients with persistent generalized lymphadenopathy in a prospective longitudinal study. Patients with serum beta-2-microglobulin greater than 2.6 mg/l were found to have a significantly higher risk of developing AIDS earlier when compared to patients with a lower level (p less than 0.001).
authors.affiliation: Department of Infectious Diseases, Roslagstull Hospital, Karolinska Institute, Stockholm.
authors.forename: J
authors.initials: J
authors.lastname: Morfeldt-Månson
authors.forename: I
authors.initials: I
authors.lastname: Julander
authors.forename: L V
authors.initials: LV
authors.lastname: von Stedingk
authors.forename: J
authors.initials: J
authors.lastname: Wasserman
authors.forename: B
authors.initials: B
authors.lastname: Nilsson
mesh_terms: D000386:AIDS-Related Complex / Q000097:blood*; D000163:Acquired Immunodeficiency Syndrome / Q000175:diagnosis*; D006801:Humans; D008137:Longitudinal Studies; D011379:Prognosis; D011446:Prospective Studies; D012307:Risk Factors; D013997:Time Factors; D001613:beta 2-Microglobulin / Q000032:analysis*
chemical_list: D001613:beta 2-Microglobulin